Heba S. Said and colleagues enrolled patients with IBD (14 CD and 10 UC) and 15 healthy controls and, also, performed an analysis of immunological biomarkers in the saliva of IBD, such as cytokines, secretory IgA, and lysozymes. Here, CD79A is linked to inflammatory bowel disease.